2016
DOI: 10.1016/j.lungcan.2016.08.007
|View full text |Cite
|
Sign up to set email alerts
|

Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

6
76
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 108 publications
(82 citation statements)
references
References 25 publications
6
76
0
Order By: Relevance
“…In hepatopancreatobiliary cancer, low SMM is associated with reduced OS . In patients with resectable early stage non‐small‐cell lung cancer, low SMM is associated with poor short‐term and long‐term outcomes after surgery . Low SMM has also been associated with prolonged hospital stay and increased health care‐related costs.…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…In hepatopancreatobiliary cancer, low SMM is associated with reduced OS . In patients with resectable early stage non‐small‐cell lung cancer, low SMM is associated with poor short‐term and long‐term outcomes after surgery . Low SMM has also been associated with prolonged hospital stay and increased health care‐related costs.…”
Section: Discussionsupporting
confidence: 91%
“…14 In patients with resectable early stage non-small-cell lung cancer, low SMM is associated with poor short-term and long-term outcomes after surgery. 27,28 Low SMM has also been associated with prolonged hospital stay and increased health care-related costs. A recent study in 452 patients undergoing abdominal surgery for cancer of the alimentary tract showed that patients with low SMM had a significantly longer hospital stay and significantly higher hospital costs than patients with normal SMM.…”
Section: Discussionmentioning
confidence: 99%
“…Hervochon et al demonstrated that BMI and total psoas area at the level of L3 were independent prognostic factors for patients undergoing pneumonectomy for NSCLC (29). Suzuki et al examined 90 consecutive patients undergoing lung resection for stage I NSCLC, and using L3MI to assess for sarcopenia, found that sarcopenia was an independent prognostic factor for survival as patient with a low muscle mass had a significant decrease in 5-year overall survival (20). Tsukioka et al reported on 215 male patients with pathological stage I NSCLC, and used a calculated L3MI derived from an equation using BSA to define sarcopenia; in their report, sarcopenia did not affect short-term outcomes, but was associated with a shorter median overall survival (21).…”
Section: Discussionmentioning
confidence: 99%
“…CT imaging has been found to correlate well with other methods of evaluating muscle mass, which is useful as CT imaging is routinely done prior to resection (19). In lung cancer, recent studies have found evidence that sarcopenia is an independent risk factor for decreased overall survival (20,21). In those studies, assessment of muscle mass was done at the level of L3, which sometimes necessitates a CT scan lower than routinely performed to evaluate chest pathology.…”
Section: Introductionmentioning
confidence: 99%
“…LC can be associated with secondary sarcopenia because of protein metabolic disorder and/or energy metabolic disorder [11,14,15]. Skeletal muscle mass loss can be linked to poorer clinical outcomes in LC patients, hepatocellular carcinoma (HCC) patients, or patients with other malignancies [17,18,19,20,21,22,23,24,25,26]. Skeletal muscle mass can be assessed by computed tomography (CT), magnetic resonance imaging (MRI), dual energy X-ray absorptiometry and bioimpedance analysis (BIA), which are consistent and accurate assessment modalities [14,15,17,19,27,28].…”
Section: Introductionmentioning
confidence: 99%